DiaMedica <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Signs $100 Million Sales Agreement with TD Cowen for At-the-Market Offering
DiaMedica Therapeutics Inc. has entered into a Sales Agreement with TD Securities $(USA)$ LLC, commonly known as TD Cowen, allowing for the sale of its common shares up to an aggregate offering amount of $100 million. Under this agreement, shares may be sold at market offerings, as defined by the Securities Act of 1933. TD Cowen, acting as the sales agent, is not obligated to sell a specific number of shares but will use commercially reasonable efforts to facilitate the sales. The company has agreed to compensate TD Cowen with up to 3% of the gross proceeds from the sales, and will also cover certain costs and provide indemnification related to the sales process. This agreement marks a strategic move for DiaMedica to raise capital through public offerings, although no specific timeline or amount for the share sales has been disclosed.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DiaMedica Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-026286), on August 12, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.